Renal Cachexia Dr Joanne Reid School of Nursing and Midwifery - - PowerPoint PPT Presentation

renal cachexia
SMART_READER_LITE
LIVE PREVIEW

Renal Cachexia Dr Joanne Reid School of Nursing and Midwifery - - PowerPoint PPT Presentation

Renal Cachexia Dr Joanne Reid School of Nursing and Midwifery Queens University Belfast j.reid@qub.ac.uk Cachexia Cachexia is a complex metabolic syndrome associated with underlying illness and characterised by muscle loss, with or


slide-1
SLIDE 1

Renal Cachexia

Dr Joanne Reid School of Nursing and Midwifery Queen’s University Belfast j.reid@qub.ac.uk

slide-2
SLIDE 2

Cachexia

  • Cachexia is ‘a complex metabolic syndrome

associated with underlying illness and characterised by muscle loss, with or without loss of fat’

  • Definition of cachexia in chronic illness

– weight loss of at least 5% within ≤12 months or Body Mass Index (BMI) <20 kg/m2

  • plus three of the following five features:

– decreased muscle strength; – fatigue; – anorexia; – low fat-free mass index; – abnormal biochemistry (increased inflammatory markers [CRP, IL-6], anaemia [Hb <120 g/L], low serum albumin [<32g/L] (Evans et al. 2008).

Evans et al. (2008). Cachexia, a new definition. Clinical Nutrition 27,793–799.

slide-3
SLIDE 3

Pathogenesis of cachexia

  • Multifacorial

Reduced food intake Alterations in metabolism Accelerated muscle and fat loss

slide-4
SLIDE 4

Importance of the problem - cachexia

Cachexia is linked with poor outcomes for the patients

 Presence of the cachectic syndrome, associated with any chronic disease trajectory, increases mortality

 is responsible for about one quarter of cancer deaths.

Cachexia causes great morbidity, limits therapy No standardised ‘best treatment’ for cachexia Lack of guidelines / protocols in clinical practice

slide-5
SLIDE 5

Importance of the problem – cachexia in renal disease

 Between 30-60% of advanced CKD patients will have cachexia – Among potential candidates to explain the high rate of morbidity and mortality and cardiovascular disease in CKD patients, cachexia continues to top the list.  Limited attention has been devoted to cachexia in renal disease  For renal cachexia there are no standardised definitions

  • r inclusion criteria to help inform practice or research
slide-6
SLIDE 6

Management of cachexia in renal disease

  • Challenging – definition needs refinement for

renal population

  • Discriminating cachexia from other causes of

malnutrition

  • Clinically differentiate between cachexia and

Protein energy wasting as each state may require distinct management strategies

slide-7
SLIDE 7

Previous cachexia work: advanced cancer population

Reid et al (2009). The experience of cancer cachexia: A qualitative study of advanced cancer patients and their family members. International Journal of Nursing Studies, 46(5), 606-616.

slide-8
SLIDE 8

Renal cachexia work completed by Reid and colleagues

Belfast based working group established Review paper: Reid et al. (2013). A literature review of end-stage renal disease and cachexia: understanding experience to inform evidence-based healthcare. Journal of Renal Care 39(1), 47–51. Workshops (funding secured through R&D Office) 1) Belfast to UK working group (BRS conference, 2014) 2) UK to International working group (Belfast workshop, 2014) Consensus of defining foci and forward planning Editorial: Reid et al (2015) Defining cachexia in a renal population. Journal of Renal Care 41(2), 79-80 . Includes colleagues from UK, USA and EU Planned application for NI then UK - epidemiological study

slide-9
SLIDE 9

Working group / collaborators

Starting point for working group (first publication)

  • Joanne Reid - QUB
  • Helen Noble - QUB
  • Sam Porter - QUB
  • Joanne Shields - BHSCT
  • Peter Maxwell - BHSCT / QUB

Current working group (last publication and grant collaborators)

  • Joanne Reid - QUB
  • Helen Noble - QUB
  • Sam Porter - QUB
  • Joanne Shields - BHSCT
  • Peter Maxwell - BHSCT / QUB
  • Ken Farrington – England
  • Mark wright – England
  • Adrian Slee - England
  • Andrew Davenport - England
  • Miles Whitman - Scotland
  • Denis Fouque - France
  • David Seres – USA
slide-10
SLIDE 10
  • Questions?
  • Please contact j.reid@qub.ac.uk